GO:0043610 regulation of carbohydrate utilization: Metabolic Control Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0043610 (regulation of carbohydrate utilization) is a biological process that modulates the rate, extent, or efficiency of carbohydrate consumption by cells, often through transcriptional regulators that sense sugar availability.
In bacteria such as Lactobacillus plantarum, regulators like AcrR and Rex cross-regulate aldehyde-alcohol dehydrogenase (AdhE) to control mannitol and sorbitol utilization, illustrating a direct genetic mechanism for this GO term.
In humans, dysregulation of carbohydrate utilization contributes to metabolic disorders including type 2 diabetes, where sugar intake and utilization are central to disease progression.
Clinical management of diabetes often involves monitoring and modulating carbohydrate utilization, as impaired regulation affects driving safety and other daily activities.
Model-based drug development approaches can be applied to study regulators of carbohydrate utilization and predict therapeutic outcomes.
Research on this process spans microbiology, metabolic disease, and pharmacology, with experimental models ranging from bacterial knockout strains to human cell lines and animal models [5,6].

Description

Regulation of carbohydrate utilization (GO:0043610) is a fundamental biological process that governs how cells and organisms take up, break down, and derive energy from carbohydrates. This process ensures metabolic homeostasis and allows rapid adaptation to changing nutrient availability. In bacteria, for example, the utilization of mannitol and sorbitol is tightly controlled by transcriptional regulators that respond to intracellular signals, as demonstrated in Lactobacillus plantarum where AcrR and Rex cross-regulate aldehyde-alcohol dehydrogenase (AdhE). Such regulatory circuits are critical for competitive fitness and survival in diverse environments. In humans, the regulation of carbohydrate utilization is equally important; impaired control contributes to metabolic diseases such as type 2 diabetes, where excessive sugar intake and altered glucose utilization drive hyperglycemia and associated complications. Understanding the molecular players and pathways that regulate carbohydrate utilization is therefore essential for developing therapeutic strategies. This article synthesizes current knowledge on the mechanisms, key genes, and research methods relevant to GO:0043610, drawing on authoritative literature to provide a comprehensive overview for researchers and clinicians.

regulation of carbohydrate utilization At A Glance

GO ID GO:0043610
GO term regulation of carbohydrate utilization
Ontology biological_process
Synonym None listed in QuickGO
Major function Modulates the rate, extent, or efficiency of carbohydrate catabolism and uptake
Key regulators Transcriptional factors such as AcrR and Rex in bacteria; hormonal signals in mammals
Associated diseases Type 2 diabetes, metabolic syndrome, and other disorders of glucose homeostasis
Research models Bacterial knockout strains, mammalian cell lines, animal models of diabetes

What Is GO:0043610?

Regulation of carbohydrate utilization (GO:0043610) refers to any process that modulates the frequency, rate, or extent of carbohydrate utilization, the biological process in which carbohydrates are taken up and catabolized to produce energy and metabolic intermediates. This regulation can occur at multiple levels, including transcriptional control of genes encoding carbohydrate transporters and enzymes, post-translational modification of metabolic enzymes, and sensing of intracellular metabolite levels. In microbial systems, regulators such as AcrR and Rex directly bind to promoter regions of genes involved in mannitol and sorbitol utilization, adjusting their expression in response to available substrates. In higher organisms, hormonal and nutritional signals coordinate carbohydrate utilization across tissues to maintain blood glucose homeostasis.

Why Is regulation of carbohydrate utilization Important in Cell Biology?

Regulation of carbohydrate utilization is central to energy metabolism and metabolic health across all domains of life. In pathogenic and commensal bacteria, the ability to efficiently utilize available carbohydrates determines colonization success and competitive fitness. In humans, dysregulated carbohydrate utilization is a hallmark of type 2 diabetes and related metabolic disorders, where chronic excess sugar intake leads to insulin resistance and hyperglycemia. Moreover, understanding how carbohydrate utilization is regulated can inform drug development, as model-based approaches can predict the effects of modulating these pathways. Clinically, patients with diabetes must manage their carbohydrate intake and utilization to avoid acute complications, including impaired driving performance due to hypoglycemia. Thus, research on GO:0043610 has broad implications for microbiology, medicine, and pharmacology.
Controls energy homeostasis by adjusting carbohydrate breakdown to meet cellular demands.
Enables bacteria to adapt to changing nutrient environments and outcompete rivals.
Dysregulation contributes to type 2 diabetes and metabolic syndrome.
Impacts clinical management of diabetes, including driving safety and lifestyle recommendations.
Provides targets for drug development, with model-based approaches aiding prediction of therapeutic effects.
Influences microbial fermentation processes important in food and biotechnology industries.
Affects maternal and fetal health in conditions like sepsis, where metabolic stress alters carbohydrate utilization.
Relevant to biosimilar development and real-world utilization of biologics in metabolic diseases.
Can be studied using CRISPR-based gene editing to dissect regulatory networks.
Offers insights into evolutionary adaptation of metabolic pathways across species.

What Happens During regulation of carbohydrate utilization?

Sensing of Carbohydrate Availability
In simple terms: Cells first detect which sugars are present and how much.
The regulation of carbohydrate utilization begins with sensing the availability of specific carbohydrates. In bacteria, regulators such as AcrR and Rex respond to intracellular levels of metabolites or redox states, allowing them to modulate gene expression accordingly. For example, in Lactobacillus plantarum, Rex senses redox balance and controls the expression of adhE, which encodes aldehyde-alcohol dehydrogenase, an enzyme involved in mannitol and sorbitol utilization. This sensing ensures that carbohydrate catabolism is activated only when substrates are available and needed.
Transcriptional Control of Utilization Genes
In simple terms: Special proteins turn the relevant genes on or off.
Once a signal is sensed, transcriptional regulators bind to DNA and alter the expression of genes encoding carbohydrate transporters and catabolic enzymes. AcrR and Rex cross-regulate the adhE gene in L. plantarum, demonstrating a direct mechanism by which carbohydrate utilization is controlled at the transcriptional level. This regulation can be repressive or activating, depending on the regulator and the metabolic context, and ensures that the cell invests resources in utilizing available carbohydrates efficiently.
Post-Transcriptional and Post-Translational Modulation
In simple terms: The activity of enzymes can be tweaked after they are made.
Beyond transcription, carbohydrate utilization can be regulated by modifying the activity of enzymes involved in glycolysis and fermentation. While specific post-translational modifications in the context of GO:0043610 are not detailed in the provided citations, general principles of metabolic regulation suggest that feedback inhibition and covalent modification fine-tune flux through these pathways. In bacteria, AdhE activity can be influenced by redox state, linking its function to the cellular environment.
Integration with Global Metabolic Networks
In simple terms: Carbohydrate use is connected to other metabolic processes.
Regulation of carbohydrate utilization is integrated with other metabolic pathways to maintain energy balance. In L. plantarum, the cross-regulation of adhE by AcrR and Rex ties mannitol and sorbitol utilization to overall redox homeostasis and carbon metabolism. In humans, hormonal signals such as insulin coordinate carbohydrate utilization across tissues, and disruptions in this integration lead to metabolic diseases like type 2 diabetes. Thus, this process is not isolated but part of a larger regulatory network.
Physiological Outcomes and Adaptation
In simple terms: The end result is that cells use sugars appropriately for energy.
The ultimate outcome of regulating carbohydrate utilization is the efficient production of energy and metabolic intermediates while avoiding wasteful or toxic accumulation of sugars. In bacteria, this regulation supports growth on specific carbon sources and contributes to niche adaptation. In humans, proper regulation maintains blood glucose levels, and its failure results in hyperglycemia and associated complications. Clinical management of diabetes often focuses on modulating carbohydrate intake and utilization to prevent acute and chronic sequelae.

Key Genes Involved in GO:0043610 regulation of carbohydrate utilization

The following genes and proteins are key players in the regulation of carbohydrate utilization, based on experimental evidence from bacterial and mammalian systems.
GeneMajor RoleResearch Relevance
AcrRTranscriptional regulator that represses adhE and modulates mannitol/sorbitol utilization in L. plantarumStudied via knockout and overexpression to dissect regulatory networks
RexRedox-sensing transcriptional regulator that cross-regulates adhE with AcrRTarget for understanding redox-linked carbohydrate control
AdhEAldehyde-alcohol dehydrogenase involved in fermentation of mannitol and sorbitolEnzyme whose expression is controlled by AcrR and Rex
INSInsulin, key hormone regulating glucose uptake and utilization in mammalsCentral to diabetes research and carbohydrate metabolism
INSRInsulin receptor, mediates insulin signaling for glucose utilizationTarget for studying insulin resistance in type 2 diabetes
SLC2A4GLUT4 glucose transporter, facilitates glucose uptake in muscle and fatModel for studying regulated carbohydrate utilization in diabetes
GCKGlucokinase, phosphorylates glucose in liver and pancreasKey enzyme in glucose sensing and utilization
PFKMPhosphofructokinase, rate-limiting enzyme in glycolysisTarget for modulating glycolytic flux
PKMPyruvate kinase, final step of glycolysisStudied for its role in metabolic reprogramming
LDHALactate dehydrogenase A, converts pyruvate to lactateRelevant to anaerobic carbohydrate utilization
PDHPyruvate dehydrogenase, links glycolysis to TCA cycleRegulated by phosphorylation to control carbohydrate oxidation
AMPKEnergy sensor that promotes carbohydrate catabolismCentral regulator of energy homeostasis
mTORKinase that integrates nutrient signals to control metabolismModulates carbohydrate utilization in response to nutrients
FOXO1Transcription factor regulating gluconeogenesis and glucose utilizationTarget in diabetes and metabolic disease
PPARGC1APGC-1alpha, coactivator regulating mitochondrial biogenesis and glucose metabolismStudied for its role in insulin sensitivity
SLC2A2GLUT2 glucose transporter, important in liver and pancreatic beta cellsModel for glucose sensing and utilization
HK2Hexokinase 2, phosphorylates glucose in glycolysisTarget for cancer metabolism and diabetes research
G6PCGlucose-6-phosphatase, catalyzes final step of gluconeogenesisRegulated in response to carbohydrate availability

How Is regulation of carbohydrate utilization Regulated?

The regulation of carbohydrate utilization is itself subject to multiple layers of control. In bacteria, the activity of transcriptional regulators such as AcrR and Rex is modulated by intracellular signals, including redox state and metabolite concentrations, allowing rapid adaptation to environmental changes. In mammals, hormonal signals, particularly insulin and glucagon, orchestrate carbohydrate utilization across tissues. Insulin promotes glucose uptake and utilization, while glucagon stimulates glucose production. These hormonal controls are integrated with nutrient-sensing pathways involving AMPK and mTOR, which respond to energy status and amino acid availability. Dysregulation of these regulatory mechanisms underlies insulin resistance and type 2 diabetes, making them key targets for therapeutic intervention.

regulation of carbohydrate utilization and Human Disease

GeneDisease / BiologyPotential Experimental Model
AcrRBacterial carbohydrate utilization and gut colonizationLactobacillus plantarum knockout and overexpression strains
RexRedox-linked regulation of fermentationBacterial mutants and reporter assays
INSType 2 diabetes and insulin resistanceHuman cell lines and animal models of diabetes
SLC2A4Impaired glucose uptake in muscle and fatKnockout mice and adipocyte cell lines
GCKMaturity-onset diabetes of the young (MODY)Hepatocyte and beta-cell models
Type 2 Diabetes and Metabolic Syndrome
Type 2 diabetes is characterized by impaired regulation of carbohydrate utilization, leading to chronic hyperglycemia and insulin resistance. Excessive intake of sugars, particularly refined carbohydrates, contributes to the development and progression of the disease. Clinical management focuses on modulating carbohydrate intake and improving utilization through lifestyle and pharmacological interventions. Patients with diabetes must also manage their condition while driving, as hypoglycemia can impair driving performance. Thus, understanding the regulation of carbohydrate utilization is essential for preventing and treating type 2 diabetes.
Microbial Infections and Gut Colonization
In pathogenic and commensal bacteria, the ability to regulate carbohydrate utilization is critical for survival and colonization. For example, Lactobacillus plantarum uses regulators AcrR and Rex to control mannitol and sorbitol utilization, which may affect its competitiveness in the gut. Disruption of these regulatory pathways could alter microbial communities and influence host health. Research on bacterial carbohydrate regulation can inform probiotic development and strategies to combat pathogens.
Maternal Sepsis and Metabolic Stress
Maternal sepsis and septic shock are severe conditions that can disrupt metabolic homeostasis, including carbohydrate utilization. The systemic inflammatory response can lead to altered glucose metabolism and insulin resistance, complicating clinical management. Understanding how carbohydrate utilization is regulated during sepsis may help optimize supportive care for affected patients.
Biosimilar Utilization in Metabolic Diseases
The real-world utilization of biosimilars, such as epoetin zeta, highlights the importance of monitoring treatment outcomes in metabolic and hematologic diseases. While not directly about carbohydrate utilization, this example underscores how regulation of biological processes can impact therapeutic strategies. In the context of diabetes, biosimilar insulins are used to regulate carbohydrate utilization, and their efficacy and safety are monitored in clinical practice.

From regulation of carbohydrate utilization-Related Genes to Experimental Models

Research QuestionSuitable Model
Does AcrR directly repress adhE?Knockout of acrR in L. plantarum followed by qRT-PCR and ChIP
What is the role of Rex in redox sensing?Point mutations in Rex redox-sensing cysteines
How does insulin regulate glucose uptake?Knockout of INSR in adipocytes or myotubes
Can overexpression of GCK improve glucose utilization?Adenoviral overexpression in hepatocytes
What is the effect of AMPK activation on carbohydrate utilization?Knock-in of constitutively active AMPK in mouse models
How does mTORC1 modulate glycolysis?Knockout of raptor in T cells

How to Study the regulation of carbohydrate utilization Process

MethodWhat It MeasuresTypical Application
RNA-seqGlobal gene expression changesIdentifying regulons controlled by carbohydrate regulators
qRT-PCRExpression of specific genesValidating adhE repression by AcrR
ChIP-seqGenome-wide binding sites of regulatorsMapping AcrR and Rex binding in L. plantarum
13C metabolic flux analysisFlux through metabolic pathwaysQuantifying glycolytic flux in response to genetic changes
Growth assaysAbility to utilize specific carbohydratesPhenotyping bacterial mutants
Western blotProtein levels of metabolic enzymesAssessing AdhE expression
Enzyme activity assaysCatalytic activity of metabolic enzymesMeasuring AdhE or glycolytic enzyme activity
CRISPR screensGenes required for carbohydrate utilizationIdentifying novel regulators in mammalian cells
Transcriptional Analysis (RNA-seq, qRT-PCR)
RNA sequencing and quantitative RT-PCR are used to measure changes in gene expression related to carbohydrate utilization. For example, knockout of acrR in L. plantarum leads to altered adhE expression, which can be quantified by qRT-PCR. In mammalian systems, RNA-seq can reveal global transcriptional responses to changes in glucose availability.
Metabolic Flux Analysis
Metabolic flux analysis using isotope-labeled substrates (e.g., 13C-glucose) measures the rate of carbohydrate utilization through specific pathways. This technique can determine how genetic perturbations affect glycolytic flux and fermentation [5,6].
Chromatin Immunoprecipitation (ChIP)
ChIP assays are used to detect direct binding of transcriptional regulators to target gene promoters. For instance, ChIP can confirm AcrR binding to the adhE promoter in L. plantarum.
Phenotypic Growth Assays
Growth assays on minimal media containing specific carbohydrates (e.g., mannitol, sorbitol) assess the ability of bacterial strains to utilize those substrates. Deletion of regulatory genes often results in growth defects under these conditions.

How CRISPR Can Be Used to Study GO:0043610 regulation of carbohydrate utilization

Knockout

CRISPR knockout is used to delete genes encoding regulators or enzymes involved in carbohydrate utilization. For example, knocking out acrR in L. plantarum can reveal its role in repressing adhE and controlling mannitol/sorbitol utilization. In mammalian cells, knockout of INSR or SLC2A4 can model insulin resistance and impaired glucose uptake.

Point Mutation

Point mutations can be introduced to dissect specific functional domains. For instance, mutating redox-sensing cysteines in Rex can test its role in sensing redox state and regulating adhE. In human GCK, point mutations can mimic MODY-associated variants to study their effect on glucose utilization.

Knock-in

Knock-in of reporter genes or tags allows visualization and quantification of carbohydrate utilization regulators. For example, knocking in a fluorescent tag at the adhE locus in L. plantarum enables live-cell imaging of its expression. In mice, knock-in of human mutant alleles can model metabolic diseases.

Overexpression

Overexpression of key regulators or enzymes can enhance or disrupt carbohydrate utilization. Overexpressing adhE in L. plantarum may increase fermentation capacity. In mammalian cells, overexpression of GCK or SLC2A4 can increase glucose uptake and utilization, providing insights into therapeutic strategies.

How EDITGENE Supports regulation of carbohydrate utilization Research

Researchers studying regulation of carbohydrate utilization-related genes often need to determine whether a candidate gene is causally involved in metabolic control or is merely a biomarker. CRISPR-based gene editing provides a robust approach to establish causality by creating precise genetic perturbations in relevant cell models and organisms. EDITGENE offers a comprehensive suite of services to support such investigations, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of carbohydrate utilization research.

Frequently Asked Questions About regulation of carbohydrate utilization

GO:0043610 is the Gene Ontology term for regulation of carbohydrate utilization, a biological process that modulates the rate or extent of carbohydrate catabolism and uptake.
Key genes include AcrR and Rex in bacteria, which regulate adhE and mannitol/sorbitol utilization, as well as insulin (INS), insulin receptor (INSR), and glucose transporters like SLC2A4 in mammals.
In bacteria such as Lactobacillus plantarum, transcriptional regulators AcrR and Rex sense intracellular signals and cross-regulate the adhE gene to control mannitol and sorbitol utilization.
Dysregulation is linked to type 2 diabetes, metabolic syndrome, and complications such as impaired driving due to hypoglycemia [4,6].
CRISPR knockout, point mutation, knock-in, and overexpression can be used to perturb candidate genes and assess their effects on carbohydrate utilization in bacterial and mammalian models [5,6].
Methods include RNA-seq, qRT-PCR, ChIP, metabolic flux analysis, and growth assays on specific carbohydrates [5,6].
Proper regulation maintains blood glucose homeostasis; its failure leads to hyperglycemia and insulin resistance, hallmarks of type 2 diabetes.
AcrR is a transcriptional regulator that represses adhE, thereby modulating mannitol and sorbitol utilization in Lactobacillus plantarum.
Rex senses redox state and cross-regulates adhE with AcrR, linking carbohydrate utilization to cellular redox balance.
Yes, model-based approaches can predict the effects of modulating carbohydrate utilization pathways and guide therapeutic development.

Conclusion

Regulation of carbohydrate utilization (GO:0043610) is a critical biological process with broad implications for microbial physiology and human metabolic health. Key regulators such as AcrR and Rex in bacteria and insulin signaling components in mammals control the efficient use of carbohydrates. Dysregulation contributes to type 2 diabetes and other metabolic disorders, making this process a prime target for therapeutic intervention. Advances in CRISPR gene editing and metabolic analysis provide powerful tools to dissect these regulatory networks and develop new treatments.

References

  1. 3. Lalonde RL et al.. 2007. Model-based drug development.. Clin Pharmacol Ther 82(1):21-32 PMID: 17522597
  2. 4. Inkster B et al.. 2013. Diabetes and driving.. Diabetes Obes Metab 15(9):775-83 PMID: 23350766
  3. 5. Yang X et al.. 2019. AcrR and Rex Control Mannitol and Sorbitol Utilization through Their Cross-Regulation of Aldehyde-Alcohol Dehydrogenase (AdhE) in Lactobacillus plantarum.. Appl Environ Microbiol 85(4) PMID: 30530710
  4. 6. Lean ME et al.. 2016. Sugar and Type 2 diabetes.. Br Med Bull 120(1):43-53 PMID: 27707695
  5. 7. Chebbo A et al.. 2016. Maternal Sepsis and Septic Shock.. Crit Care Clin 32(1):119-35 PMID: 26600449
  6. 8. Dingermann T et al.. 2016. Biosimilar epoetin zeta: extrapolation of indications and real world utilization experience.. Expert Opin Biol Ther 16(7):967-74 PMID: 27227424
Contact Us
*
*
*
*
How did you hear about us: